EPS8
EPS8 (EPS8 Signaling Adaptor) - Gene Overview and Clinical Significance
Gene Information Card
| Symbol | EPS8 |
|---|---|
| Full Name | EPS8 signaling adaptor |
| Gene Type | protein-coding |
| Chromosomal Location | 12q23.1 |
| NCBI Gene ID | 2059 ncbi.nlm.nih.gov/gene/2059 |
| Ensembl ID | ENSG00000111057 |
| UniProt ID | Q12929 |
| OMIM ID | 600206 |
| HGNC ID | 3420 |
| Aliases | EPS-8, EPS8L1, FLJ23356 |
Description
The EPS8 gene encodes a signaling adaptor protein involved in the regulation of cell proliferation, differentiation, and cytoskeletal organization. EPS8 functions as a substrate for the epidermal growth factor receptor (EGFR) kinase and participates in receptor endocytosis, actin remodeling, and signal transduction via the RAS/MAPK and PI3K/AKT pathways. It is implicated in various cancers and developmental disorders.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Colorectal cancer | EPS8 overexpression enhances EGFR signaling and cell migration | COSMIC, ClinVar |
| Breast cancer | Amplification and overexpression of EPS8 promote tumor growth and metastasis | COSMIC, NCBI |
| Hepatocellular carcinoma | EPS8 upregulation correlates with poor prognosis and increased invasion | COSMIC |
| Prostate cancer | EPS8 variants associated with aggressive disease | ClinVar |
| Intellectual disability | De novo missense mutations in EPS8 linked to neurodevelopmental phenotypes | ClinVar, OMIM |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | 12.5 | Medium |
| Lung | 8.3 | Low |
| Liver | 6.1 | Low |
| Colon | 15.2 | Medium |
| Breast | 9.8 | Low |
| Prostate | 11.4 | Medium |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HeLa | 14.7 | Cervical cancer cell line |
| A549 | 10.2 | Lung cancer cell line |
| MCF7 | 18.3 | Breast cancer cell line |
| HepG2 | 7.5 | Liver cancer cell line |
| PC3 | 13.1 | Prostate cancer cell line |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1234C>T (p.Arg412Cys) | Missense | <0.01 | Altered EGFR binding affinity |
| c.567_569del (p.Glu189del) | In-frame deletion | <0.01 | Impaired actin remodeling |
| c.2101G>A (p.Gly701Arg) | Missense | <0.01 | Gain-of-function in cancer cell lines |
| c.45+1G>T | Splice donor | <0.01 | Loss of function, reduced protein expression |
Mutation functional classification
Loss of Function (LOF)
Splice-site and truncating mutations reduce EPS8 protein levels, impairing EGFR endocytosis and actin dynamics.
Gain of Function (GOF)
Missense mutations (e.g., p.Gly701Arg) enhance EPS8-mediated signaling, promoting cell proliferation and migration.
Dominant Negative (DN)
Deletion mutants (e.g., p.Glu189del) disrupt normal EPS8 function by interfering with protein-protein interactions.
View complete mutation data:
Gene Ontology (GO)
Pathways
• EGFR tyrosine kinase inhibitor resistance (KEGG hsa01521)
• RAS signaling pathway (KEGG hsa04014)
• PI3K-Akt signaling pathway (KEGG hsa04151)
• Regulation of actin cytoskeleton (KEGG hsa04810)
Protein Summary
EPS8 is a 822-amino-acid protein (UniProt Q12929) that contains an N-terminal phosphotyrosine-binding (PTB) domain, a central SH3 domain, and a C-terminal effector region. It acts as a scaffold linking EGFR to downstream effectors such as SOS1 and PI3K. EPS8 also directly binds actin and regulates cytoskeletal dynamics through its interaction with the WAVE complex. Post-translational modifications include tyrosine phosphorylation by EGFR and serine/threonine phosphorylation by MAPK.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| EPS8 Knockout HEK293 Cell Line | EDJ-KQ4546 | Human | 2059 | Details Get a Quote |
| EPS8L1 Knockout HEK293 Cell Line | EDJ-KQ13307 | Human | 54869 | Details Get a Quote |
| EPS8L2 Knockout HEK293 Cell Line | EDJ-KQ13309 | Human | 64787 | Details Get a Quote |
| EPS8L3 Knockout HEK293 Cell Line | EDJ-KQ13310 | Human | 79574 | Details Get a Quote |
| EPS8 Knockout A-549 Cell Line | EDJ-KQ27173 | Human | 2059 | Details Get a Quote |
| EPS8 Knockout HCT 116 Cell Line | EDJ-KQ27174 | Human | 2059 | Details Get a Quote |
| EPS8 Knockout HeLa Cell Line | EDJ-KQ25915 | Human | 2059 | Details Get a Quote |
| EPS8L1 Knockout HCT 116 Cell Line | EDJ-KQ41528 | Human | 54869 | Details Get a Quote |
| EPS8L1 Knockout A-549 Cell Line | EDJ-KQ42762 | Human | 54869 | Details Get a Quote |
| EPS8L1 Knockout HeLa Cell Line | EDJ-KQ42763 | Human | 54869 | Details Get a Quote |
| EPS8L2 Knockout A-549 Cell Line | EDJ-KQ42764 | Human | 64787 | Details Get a Quote |
| EPS8L2 Knockout HCT 116 Cell Line | EDJ-KQ42765 | Human | 64787 | Details Get a Quote |
| EPS8L2 Knockout HeLa Cell Line | EDJ-KQ42766 | Human | 64787 | Details Get a Quote |
| EPS8L3 Knockout A-549 Cell Line | EDJ-KQ42767 | Human | 79574 | Details Get a Quote |
| EPS8L3 Knockout HeLa Cell Line | EDJ-KQ57182 | Human | 79574 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records